[ET Net News Agency, 11 April 2024] TRANSCENTA-B (06628) fell 16.3% to HK$1.44.
It hits an intra-day low of HK$1.45, hitting a historical low, and an intra-day high of
HK$1.65. The total shares traded was 88,000, with a value of HK$136,010. The active
buy/sell ratio is 31:69, with net selling turnover of HK$51,110. FUTU SEC INT'L accounts
for greatest net responsive buying turnover of HK$13,536, with volume weighted average
price of HK$1.574. UBS accounts for greatest net responsive selling turnover of HK$13,758,
with volume weighted average price of HK$1.572. The stock has fallen a combined 26.5% over
the past 3 consecutive trading days.

Basic Information
=================

----------------------------------
Nominal 1.440 % Chg -16.28%
High 1.650 Low 1.450
Shares Tr 88,000 Turnover 136,010
10-D SMA 1.937 %H.V 79.298
20-D SMA 2.026 VWAP 1.546
50-D SMA 2.538 RSI14 23.101
----------------------------------
Status: Hitting a historical low, active buy/sell ratio is 31:69, with net selling
turnover of HK$51,110, falling a combined 26.5% over the past 3 consecutive trading days

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
TRANSCENTA-B (06628) 1.44 -16.28
GENSCRIPT BIO (01548) 12.68 -2.91
INNOVENT BIO (01801) 37.50 Unchanged
EVEREST MED-B (01952) 25.95 +0.19
WUXI BIO (02269) 14.00 -2.37
TIGERMED (03347) 33.20 -2.21
BEIGENE (06160) 88.90 -4.61
SCICLONE PHARMA (06600) 17.88 Unchanged
AKESO (09926) 48.70 +0.10
REMEGEN (09995) 33.30 +7.42
-----------------------------------------------
(ed)